Gerhardt Attard

Also affiliated with University College London Hospitals NHS Foundation Trust, Cancer Research UK, CRUK Lung Cancer Centre of Excellence, University College London

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Accumulation of copy number alterations and clinical progression across advanced prostate cancer”.

Accumulation of copy number alterations and clinical progression across advanced prostate cancer

Genome Medicine(2022)10.1186/s13073-022-01080-4

N/A

0.889DataRank · unranked

30 citations

Stefanie Friedrich, Chris Brawley, Larissa Mendes, Marina Parry, Adnan Ali +28 more

Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer

Annals of Oncology(2025)10.1016/j.annonc.2025.07.003

N/A

0.663DataRank · unranked

31 citations

K.N. Chi, Neal D. Shore, Ken Herrmann, Johann S. De Bono, Daniel Castellano +88 more

External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol

The Lancet Digital Health(2025)10.1016/j.landig.2025.100885

N/A

0.573DataRank · unranked

17 citations

Larissa Mendes, Vinnie Y.T. Liu, Emily Grist, Songwan Joun, Rikiya Yamashita +35 more

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.009

N/A

0.214DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Jeffry Simko +17 more

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent subpopulations of cells associated with relapse of prostate cancer

Research Square(2021)10.21203/rs.3.rs-384422/v1

N/A

0DataRank · unranked

0 citations

Nikolai Engedal, Shaolong Cao, Florian Handle, Andrew Erickson, Stefan Preković +28 more

Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0754

N/A

0DataRank · unranked

62 citations

Orsetta Quaini, Kei Mizuno, Francesco Orlando, Yari Ciani, Sheng-Yu Ku +23 more

Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer

Annals of Oncology(2023)10.1016/j.annonc.2023.04.515

N/A

0DataRank · unranked

28 citations

Amol C. Shetty, Alex Hakansson, Kim Van der Eecken, Yang Song, Y. Liu +27 more

Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.07.014

N/A

0DataRank · unranked

12 citations

Amol C. Shetty, Yang Song, Theresa Hodges, Tung Hoang, Zaker Rana +11 more

Basal-luminal subtyping of localized high-risk prostate cancer and benefit of adding docetaxel to definitive radiotherapy with androgen suppression in the NRG Oncology/RTOG 0521 phase III trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5094

N/A

0DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Felix Y. Feng +15 more

Landscape and impact of germline pathogenic variants (PVs) in metastatic hormone sensitive prostate cancer (mHSPC): Ancillary study of E3805 CHAARTED.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5082

N/A

0DataRank · unranked

2 citations

Tyler M Chinsky, M Cristian Vergara, Emily Grist, Gerhardt Attard, Eliezer M. Van Allen +3 more

Digital Pathology–based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer

European Urology Oncology(2024)10.1016/j.euo.2024.11.009

N/A

0DataRank · unranked

13 citations

Yi Ren, Meghan Tierney, Trevor J. Royce, Rikiya Yamashita, Danielle Croucher +13 more

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers

Cell(2025)10.1016/j.cell.2025.07.042

N/A

0DataRank · unranked

24 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, James A. Proudfoot +42 more

Luminal B subtype as a predictive biomarker of docetaxel benefit for newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC): A correlative study of E3805 CHAARTED.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.162

N/A

0DataRank · unranked

18 citations

Victoria Wang, Yu‐Hui Chen, Felix Y. Feng, Robert B. Den, Gerhardt Attard +10 more

Transcriptome classification of PTEN inactivation to predict survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for metastatic prostate cancer (PC): An ancillary study of the STAMPEDE trials.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5003

N/A

0DataRank · unranked

2 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, J. Proudfoot +15 more

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse

Nature Communications(2021)10.1038/s41467-021-25624-1

N/A

0DataRank · unranked

122 citations

Nikolai Engedal, Shaolong Cao, Florian Handle, Andrew Erickson, Stefan Preković +28 more

Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial

Annals of Oncology(2021)10.1016/j.annonc.2021.06.003

N/A

0DataRank · unranked

77 citations

Hsin-Chieh Huang, V. Wang, Yu‐Hui Chen, Felix Y. Feng, Robert B. Den +11 more

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent subpopulations of cells associated with relapse of prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.09.430114

N/A

0DataRank · unranked

3 citations

Nikolai Engedal, Shaolong Cao, Florian Handle, Andrew Erickson, Stefan Preković +28 more